Delivery Order SPE2DB22D9353-SPE2DB25FX2BA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The award, issued on September 19, 2025, carries an ultimate completion date of October 10, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials with a ceiling value of $1,670.13. Awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, this firm fixed-price delivery order carries no set-aside designation. The contract represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,670.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for one dose vials of YF-VAX vaccine. The contract, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.99...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract was awarded on September 19, 2025, with an ultimate completion date of October 10, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $33,402.60 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency issued a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 16, 2025, and was awarded on August 25, 2025, without any set-aside designation. This delivery order represents an individual procurement action issued under DMS...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $1,113.42 for YF-VAX 1 dose vials. The award, issued on September 11, 2025, with an ultimate completion date of October 2, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a...
- The Defense Logistics Agency awarded a delivery order valued at $11,134.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract is firm fixed-price with an ultimate completion date of October 8, 2025, and was awarded on September 17, 2025. This delivery order is issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's substantial...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, was awarded without a set-aside designation. The contract represents a standard procurement action under DLA's pharmaceutical supply operations,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $66,805.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2BADelivery Order
The Defense Logistics Agency awarded a $1,670.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract, which became effective on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at approximately $500 million through November 2026, which authorizes firm fixed-price orders for a comprehensive range of pharmaceutical items supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders for medications and medical supplies including vaccines, prescription drugs, biologics, and specialty pharmaceuticals. The YF-VAX vaccine procurement exemplifies the company's ongoing role in fulfilling military health facility requirements. As a long-standing federal contractor registered in SAM.gov since 2001, DMS Pharmaceutical Group leverages its woman-owned small business status to compete effectively in DLA pharmaceutical procurement while maintaining a robust portfolio of medical product deliveries to federal healthcare systems across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/1/25 |